^
    3years
    A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer (clinicaltrials.gov)
    P2, N=20, Not yet recruiting, Jiangsu Hansoh Pharmaceutical Co., Ltd.
    Clinical • New P2 trial
    |
    HER-2 (Human epidermal growth factor receptor 2)
    |
    HR positive • HER-2 negative
    |
    HS-10342